MedPath

Spasmodryl

Brand Name: Spasmodryl

Generic Name: Dicycloverine Hydrochloride

Active
Registration Number

DRP-3670-01

Dosage Form

SYRUP

Issuance Date

August 1, 2022

Expiry Date

March 15, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength10MG/5ML
Packaging10ML AND 60 ML AMBER BOTTLE

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Synthetic anticholinergic
A
Application
Automatic Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Dicycloverine HydrochlorideActive
Monograph: Dicyclomine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform